Lexpos News

The Department of Health and Social Care (DHSC) has today (23/10/2025) confirmed the following list of price concessions for October 2025: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £6.85 Bumetanide 1mg tablets 28 £2.95 Buprenorphine 8mg sublingual tablets sugar free 7 £3.85 Clarithromycin 125mg/5ml oral suspension 70 £10.88 Clarithromycin 250mg/5ml oral suspension 70 £19.67 Duloxetine [...]

The post October 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution (Accord Healthcare Ltd) Drug Alert Number: EL(25)A/45 Date issued: 23 October 2025 Accord Healthcare Ltd is recalling a batch of Ipratropium Bromide 500 microgram/2ml Nebuliser Solution after a foil pouch was found to contain ampoules with incorrect labels intended for the Korean market. [...]

The post MHRA Class 3 Medicines Recall: Ipratropium Bromide 500 microgram / 2ml Nebuliser Solution (Accord Healthcare Ltd) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Various Products (Relonchem Ltf) Date issued: 23 October 2025 Relonchem Ltd has informed the MHRA that duplicate GTIN numbers have been assigned to certain Losartan potassium/Hydrochlorothiazide coated tablets in error and a duplicate EAN number has been assigned to certain Risperidone tablets in error. DMRC reference number: DMRC-36849945/DMRC-36701307 Marketing Authorisation [...]

The post MHRA Class 4 Medicines Notification: Various Products (Relonchem Ltd) appeared first on Community Pharmacy England.

Next Wednesday (29th November 2025), is the planned ‘go live’ date for the expansion of the Pharmacy Contraception Service (PCS) and the New Medicine Service (NMS). NHS England will confirm ahead of this date whether the necessary changes have been made to IT systems to allow the changes to commence from this date. Ahead of [...]

The post One week to go until planned ‘go-live’ for PCS and NMS changes appeared first on Community Pharmacy England.

This is the first of a series of articles to tackle some of the misconceptions around the Lateral Flow Device (LFD) service. The articles will cover a variety of aspects of the LFD service and aims to myth bust, to increase understanding of the service. The LFD service is no longer available from community pharmacies. [...]

The post LFD service myth busting series (#1) appeared first on Community Pharmacy England.